Quarterly Transactions Made in Acadia Pharmaceuticals Inc (ACAD)
This table provides information about the institutional ownership of Acadia Pharmaceuticals Inc (ACAD). The information is specifically focused on institutions that hold shares of ACADIA PHARMACEUTICALS INC.
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 7,401,720 | 7,426,038 | 14,827,758 | 5,792,157 | 7,249,705 | 13,041,862 | 1,785,896 | |
| Q4 2021 | 5,105,716 | 8,469,387 | 13,575,103 | 8,459,676 | 566,600 | 9,026,276 | 4,548,827 | |
| Q1 2022 | 10,232,681 | 2,632,789 | 12,865,470 | 14,478,477 | 3,571,727 | 18,050,204 | -5,184,734 | |
| Q2 2022 | 10,760,796 | 12,344,584 | 23,105,380 | 9,359,968 | 5,408,488 | 14,768,456 | 8,336,924 | |
| Q3 2022 | 7,473,997 | 5,280,665 | 12,754,662 | 4,932,567 | 84,570 | 5,017,137 | 7,737,525 | |
| Q4 2022 | 9,645,235 | 6,131,583 | 15,776,818 | 6,769,862 | 100 | 6,769,962 | 9,006,856 | |
| Q1 2023 | 12,582,864 | 6,389,985 | 18,972,849 | 10,464,682 | 600 | 10,465,282 | 8,507,567 | |
| Q2 2023 | 12,568,129 | 1,328,842 | 13,896,971 | 9,030,476 | 1,665,263 | 10,695,739 | 3,201,232 | |
| Q3 2023 | 7,510,327 | 5,106,108 | 12,616,435 | 10,270,642 | 1,977,256 | 12,247,898 | 368,537 | |
| Q4 2023 | 10,112,304 | 6,761,266 | 16,873,570 | 6,602,860 | 0 | 6,602,860 | 10,270,710 | |
| Q1 2024 | 11,316,518 | 4,844,954 | 16,161,472 | 11,196,817 | 0 | 11,196,817 | 4,964,655 | |
| Q2 2024 | 17,509,455 | 4,956,112 | 22,465,567 | 17,178,823 | 0 | 17,178,823 | 5,286,744 | |
| Q3 2024 | 9,791,209 | 3,311,310 | 13,102,519 | 11,097,702 | 0 | 11,097,702 | 2,004,817 | |